News

Avalon CEO John Schneider spoke at the 6th Annual Latin American & Canada Clinical Laboratory Symposium, Cartagena, Columbia, October 16-17, organized by Abbott Diagnostics. The title of his talk was “Economics of Cancer Biomarkers: Cost Effectiveness of HE4 in Clinical Decision Making.”
Avalon CEO John Schneider spoke at the 6th Annual Latin American & Canada Clinical Laboratory Symposium, Cartagena, Columbia, October 16-17, organized by Abbott Diagnostics. The title of his talk was “Economics of Cancer Biomarkers: Cost Effectiveness of HE4 in Clinical Decision Making.” 150 150 Avalon Health Economics LLC

Avalon CEO John Schneider spoke at the 6th Annual Latin American & Canada Clinical Laboratory Symposium, Cartagena, Columbia, October 16th and 17th. The title of his talk was “Economics of Cancer Biomarkers: Cost Effectiveness of HE4 in Clinical Decision Making Dr. Schneider’s presentation focused on a conceptual framework for exploring the economic aspects of cancer…

read more

Avalon Health Economics CEO John Schneider presented at the annual Truck Safety and Litigation Seminar hosted by Marcello & Kivisto LLC law firm
Avalon Health Economics CEO John Schneider presented at the annual Truck Safety and Litigation Seminar hosted by Marcello & Kivisto LLC law firm 150 150 Avalon Health Economics LLC

Avalon Health Economics CEO John Schneider presented at the Truck Safety and Litigation Seminar hosted by Marcello & Kivisto LLC law firm in April 2013. In his presentation Dr. Schneider spoke about motor carrier liability cases involving large medical losses, and how Avalon Health Economics uses a common health economics methodology to calculate the “reasonable…

read more

Two new consultants join Avalon Health Economics: Jeff Kamil, MD (U.S. Market Access and Reimbursement) and Stephanie Wels (Research Assistant)
Two new consultants join Avalon Health Economics: Jeff Kamil, MD (U.S. Market Access and Reimbursement) and Stephanie Wels (Research Assistant) 150 150 Avalon Health Economics LLC

Avalon Health Economics is happy to announce the addition of two new consultants to our panel. Jeff Kamil, MD, joins us in the area of U.S. market access and reimbursement. Jeff worked with John Schneider, Avalon’s CEO, several years ago when John was Director of Research at the California Association of Health Plans. Dr. Kamil…

read more

AHE presents at the 12th Annual Meeting of Physician Hospitals of America, Austin, TX “What Do We Know about the Effects of Hospital Ownership?”

AHE presents at the 12th Annual Meeting of Physician Hospitals of America, Austin, TX “What Do We Know about the Effects of Hospital Ownership?” 150 150 Avalon Health Economics LLC

https://avalonecon.com/ahe-presents-at-the-12th-annual-meeting-of-physician-hospitals-of-america-austin-tx-what-do-we-know-about-the-effects-of-hospital-ownership/

Publication: The Economics of Cancer Biomarkers

Publication: The Economics of Cancer Biomarkers 150 150 Avalon Health Economics LLC

https://avalonecon.com/publication-the-economics-of-cancer-biomarkers/

Publication: Organizational Boundaries Of Medical Practice: The Case Of Physician Ownership Of Ancillary Services

Publication: Organizational Boundaries Of Medical Practice: The Case Of Physician Ownership Of Ancillary Services 150 150 Avalon Health Economics LLC

https://avalonecon.com/publication-organizational-boundaries-of-medical-practice-the-case-of-physician-ownership-of-ancillary-services/

Publication: Tobacco Litter Costs and Public Policy: A Framework and Methodology for Considering the Use of Fees to Offset Abatement Costs

Publication: Tobacco Litter Costs and Public Policy: A Framework and Methodology for Considering the Use of Fees to Offset Abatement Costs 150 150 Avalon Health Economics LLC

https://avalonecon.com/publication-tobacco-litter-costs-and-public-policy-a-framework-and-methodology-for-considering-the-use-of-fees-to-offset-abatement-costs/
Start Typing
Loading...